Press releases | WebDisclosure

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Press releases

PRESS RELEASE

published on 06/13/2024 at 19:48, 1 year 7 months ago

Informations privilégiées / Autres communiqués
ABIONYX Pharma a passé avec succès la réunion pré-IND avec la FDA pour une étude clinique de phase 2b/3 évaluant CER-001 dans le traitement de patients atteints de sepsis. La société se prépare à déposer une demande d’IND pour lancer l'étude clinique

FDA ABIONYX Pharma Sepsis CER-001 Réunion Pré-IND
PRESS RELEASE

published on 06/13/2024 at 19:48, 1 year 7 months ago

Inside Information / Other news releases
ABIONYX Pharma completes successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial in Sepsis, marking significant progress in developing innovative therapy

FDA ABIONYX Pharma Sepsis CER-001 Pre-IND Meeting
PRESS RELEASE

published on 06/13/2024 at 19:35, 1 year 7 months ago

GTT : Descriptif du programme de rachat d'actions
Programme de rachat d'actions de GTT approuvé par l'assemblée générale mixte des actionnaires le 12 juin 2024. Objectifs, montant maximum des fonds et durée du programme détaillés

Rachat D'actions Assemblée Générale Mixte GTT Autorisation Montant Maximum Des Fonds
PRESS RELEASE

published on 06/13/2024 at 19:35, 1 year 7 months ago

GTT : Main terms and conditions of the share buy-back programme
GTT announces share buy-back programme with maximum purchase price of €190 per share and maximum amount of €704,488,650, allowing for various objectives including employee stock allocation and liquidity improvement

Share Buy-back GTT Liquidity Improvement Maximum Purchase Price Employee Stock Allocation
PRESS RELEASE

published on 06/13/2024 at 19:30, 1 year 7 months ago

ThriveSparrow Launches Action Plans and AI-Driven Employee Sentiment Analysis to Enhance Employee Engagement
ThriveSparrow launches Action Plans for enhanced employee feedback, leveraging AI for sentiment analysis and disrupting traditional performance reviews to boost engagement and performance

AI-driven ThriveSparrow Employee Feedback Action Plans Performance Reviews
PRESS RELEASE

published on 06/13/2024 at 19:30, 1 year 7 months ago

SWTHZ (SweatHouz) Appoints Dr. Susanna Søberg, PhD as Lead Science and Education Advisor
SWTHZ appoints Dr. Susanna Søberg, renowned in heat and cold therapy, to its Medical Advisory Board. Expansion plans include 100 new locations in 12 months

Expansion Contrast Therapy SWTHZ Dr. Susanna Søberg Boutique Wellness
PRESS RELEASE

published on 06/13/2024 at 19:23, 1 year 7 months ago

GEVELOT S.A.: COMMUNIQUE MISE EN OEUVRE PROGRAMME RACHAT ACTIONS 2024
Gévelot S.A. met en œuvre un programme de rachat d'actions limité à 10 % du Capital, correspondant à 75 207 actions, avec un coût financier maximum de 18 000 K€. Objectif : rachat en vue d'annulation sur décision du Conseil d'Administration. Validité jusqu'au 13 décembre 2025

Rachat D'actions Conseil D'administration Programme GEVELOT S.A. Annulation
PRESS RELEASE

published on 06/13/2024 at 19:23, 1 year 7 months ago

GEVELOT S.A.: CGM 2024 PRESS RELEASE IMPLEMENTATION OF A SHARES BUY BACK PROGRAM
GEVELOT SA's Board of Directors implements a share buyback program, authorizing the repurchase of shares for cancellation with specific financial limits until December 13, 2025

Capital Euronext Share Buyback Program GEVELOT SA Financial Cost
PRESS RELEASE

published on 06/13/2024 at 19:22, 1 year 7 months ago

GEVELOT S.A.: COMMUNIQUE MISE EN OEUVRE PROGRAMME RACHAT ACTIONS 2024
GEVELOT S.A. met en oeuvre son programme de rachat d'actions limité à 10% du capital pour un coût financier maximum de 18 000 K€ jusqu'au 13 décembre 2025

Rachat D'actions Euronext Assemblée Générale Mixte Programme GEVELOT S.A.
PRESS RELEASE

published on 06/13/2024 at 19:22, 1 year 7 months ago

GEVELOT S.A.: CGM 2024 PRESS RELEASE IMPLEMENTATION OF A SHARES BUY BACK PROGRAM
GEVELOT S.A. announces the implementation of a shares buyback program to repurchase shares for cancellation, in accordance with the Ninth Extraordinary Resolution. The buyback program is limited to 10% of the capital with a maximum financial cost set at €18,000K

Capital Repurchase GEVELOT S.A. Shares Buyback Program Financial Cost

Accesswire

Published on 02/07/2026 at 01:00, 1 day 8 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 10 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 11 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 18 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 20 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 12 hours 35 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 17 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 17 hours 15 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 14 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 15 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 15 hours ago

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 1 day 15 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 17 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 1 day 17 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 2 days 1 hour ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE